| Symbol | CGON |
|---|---|
| Name | CG ONCOLOGY, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 400 SPECTRUM CENTER DRIVE,SUITE 2040, ¿IRVINE, California, 92618, United States |
| Telephone | (949) 409-3700 |
| Fax | — |
| — | |
| Website | https://www.cgoncology.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001991792 |
| Description | CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Additional info from NASDAQ: |
📋 AMBAW BELLETE (Officer) plans to sell 826 shares of CG ONCOLOGY, INC. (at $75.00 each, total $62K) Filed: Sep 11, 2026 | ID: 009375
Read more📋 AMBAW BELLETE (Officer) plans to sell 30K shares of CG ONCOLOGY, INC. (at $77.61 each, total $2.3M) Filed: Sep 02, 2026 | ID: 009036
Read more📋 AMBAW BELLETE (Officer) plans to sell 50K shares of CG ONCOLOGY, INC. (at $75.50 each, total $3.8M) Filed: Aug 31, 2026 | ID: 008873
Read more📋 AMBAW BELLETE (Officer) plans to sell 6K shares of CG ONCOLOGY, INC. (at $79.39 each, total $460K) Filed: Aug 27, 2026 | ID: 008793
Read more📋 AMBAW BELLETE (Officer) plans to sell 11K shares of CG ONCOLOGY, INC. (at $79.55 each, total $839K) Filed: Aug 25, 2026 | ID: 008678
Read more📋 AMBAW BELLETE (Officer) plans to sell 6K shares of CG ONCOLOGY, INC. (at $79.52 each, total $458K) Filed: Aug 24, 2026 | ID: 008634
Read more📋 AMBAW BELLETE (Officer) plans to sell 100K shares of CG ONCOLOGY, INC. (at $79.54 each, total $8.0M) Filed: Aug 19, 2026 | ID: 008371
Read morePOST LEONARD E 🟡 adjusted position in 1.0K shares (1 derivative) of CG Oncology, Inc. (CGON) at $74.54 Transaction Date: Aug 14, 2026 | Filing ID: 355561
Read more